Russia's Caspian Flotilla ships will reconstruct fragment of Battle of Stalingrad
Kremlin: Russia’s appointing new envoy aimed at raising level of talks on Ukraine conflict
Russia demands explanations from Poland over denial of entry to Russian bikers
Kremlin: Paris will either deliver Mistrals or return prepayment for ships
Russia will never stop supporting its compatriots in Ukraine — Russian FM
US policy on antiballistic missile serious obstacle to nuclear disarmamentRussia April 28, 3:06
Russia demands explanations from Poland over denial of entry to Russian bikersRussia April 28, 0:43
Lavrov: Russia became target of unprecedented confrontation campaignRussia April 27, 21:54
Kremlin: Russia’s appointing new envoy aimed at raising level of talks on Ukraine conflictRussia April 27, 21:41
Russia will never stop supporting its compatriots in Ukraine — Russian FMRussia April 27, 21:26
Russian diplomat: NATO ready to breach morality, ethics to fuel anti-Russian propagandaWorld April 27, 21:12
Expansion of UN Security Council on agenda — Russia FMWorld April 27, 20:55
Kremlin refuses to comment on proposals to reduce use of foreign currencies in RussiaRussia April 27, 20:49
Kremlin hopes to continue cooperation with Turkey despite Erdogan's statement — spokesmanRussia April 27, 20:23
NOVOSIBIRSK, October 30 (Itar-Tass) - Scientists of the Institute of Clinical Immunology in the Siberian branch of the Russian Academy of Medical Sciences in Novosibirsk have developed a vaccine for the treatment of cancer, the institute's director, Professor Vladimir Kozlov, told Itar-Tass on Wednesday.
The vaccine has already successfully passed clinical tests. Currently, it is being given to patients by injection at the third and fourth stages of cancer and is reported as having increased patient lifespan more than twofold.
“We are deriving dendritic cells from the human body and loading them with tumor antigens," the scientist said. "Dendritic cells process them, then we inject the cells into the patient and they start working in the body evoking a strong immune response. That is, they are actively fighting the tumor."
The institute's creation "is not a classical vaccine, which is the means to prevent the illness", Professor Kozlov said. "In fact, it is cell therapy.”
The vaccine is counteracting several types of cancer - colorectal (bowel) cancer, breast cancer and prostate cancer - and the institute is ready to start its industrial production, Kozlov added.
He warned, however, that “one should not seek a panacea for malign tumors as they cannot be overcome with only one tool. Along with dendritic cells, there are other cells that fight cancer so all means are to be applied in complex. An immunomodulating cocktail is needed for a far-reaching effect,” Kozlov said.
Other types of therapy were to be used as well, such as chemotherapy and radiation therapy, the professor said. Treatment should vary case by case, he said, adding that the institute was already developing preventive vaccines against other illnesses, atherosclerosis among them, and that they would be presented soon.